In response to continued interest from our members in pharmacy benefit and prescription drug trends, The Council is partnering with McKinsey to conduct a survey on emerging products, solutions, benefit
June 24, 2022 The Supreme Court overturned Roe v. Wade today in a 6-3 decision. The Court’s full, 215-page opinion is available here. Our team is working through the details and impact,
On September 17, the Departments of Health and Human Services and Treasury (“Departments”) issued their final rule on 2022 benefit and payment parameters under the Affordable Care Act (“ACA”), following
NEWS RELEASE – FOR IMMEDIATE RELEASE Contact: Nicole Vasile Director, Communications (202) 756-5627 nicole.vasile@ciab.com THE COUNCIL FOUNDATION AWARDS $380,000 IN ACADEMIC SCHOLARSHIPS TO 76 INDUSTRY INTERNS WASHINGTON, D.C. – September
The Trump Administration issued final rules (initially proposed in 2018 and 2019) aimed at lowering Medicare drug costs and reducing regulatory burdens in the Medicare program.
November 16, 2020 On November 10, the Department of Treasury issued a notice of proposed rule regarding the Terrorism Risk Insurance Program (TRIP). Specifically, Treasury is proposing, among other things,
November 16, 2020 The Departments of Health and Human Services, Labor, and Treasury issued an interim final rule on November 6 to implement certain healthcare provisions under the Coronavirus Aid,
October 5, 2020 At the close of September, the Department of Health and Human Services (HHS) took action to implement two of President Trump’s drug pricing executive actions from July.
October 5, 2020 President Trump issued an Executive Order on September 24 outlining his “America First Healthcare Plan”—his proposal to reshape the nation’s healthcare system. With election day fast approaching
April 22, 2020 As the world continues to deal with the coronavirus, governments have started to get a better grasp of the economic damage caused by the crisis and have
